Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/1/06 → 6/30/12 |
Financiación
- Origin Pharmaceutical Services Ltd: 268.389,00 US$
Randomized, Double-Blind, Placebo-Controlled Phase II Trail of the Safety, Tolerability and Immunology of Lyophilized Chimerivax TM-WN02 West Nile Vaccine in Healthy Adults; Safety and Effectiveness of West Nile Vaccine in Healthy Adults
- Greenberg, Richard (PI)